| Summary of Net Revenue Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales,
operating profit, depreciation and amortization, interest expense,
income tax benefit (expense) and other comprehensive income for the
three months and nine months ended August 31, 2016:
|
|
|
|
|
|
|
|
|
| |
|
For the three months
ended August 31,
2016 |
|
|
For the nine months
ended August 31,
2016 |
|
|
Net revenue
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
6,243,803 |
|
|
$ |
16,970,939 |
|
|
Prepacyte®-CB
|
|
|
88,135 |
|
|
|
286,253 |
|
|
|
|
|
|
|
|
|
|
|
Total net revenue
|
|
$ |
6,331,938 |
|
|
$ |
17,257,192 |
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
1,482,900 |
|
|
$ |
4,073,293 |
|
|
Prepacyte®-CB
|
|
|
68,331 |
|
|
|
257,329 |
|
|
|
|
|
|
|
|
|
|
|
Total cost of sales
|
|
$ |
1,551,231 |
|
|
$ |
4,330,622 |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
27,310 |
|
|
$ |
84,542 |
|
|
Prepacyte®-CB
|
|
|
12,436 |
|
|
|
38,624 |
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization
|
|
$ |
39,746 |
|
|
$ |
123,166 |
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
808,254 |
|
|
$ |
1,864,325 |
|
|
Prepacyte®-CB
|
|
|
(1,870,329 |
) |
|
|
(1,887,594 |
) |
|
|
|
|
|
|
|
|
|
|
Total operating loss
|
|
$ |
(1,062,075 |
) |
|
$ |
(23,269 |
) |
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
199,439 |
|
|
$ |
781,971 |
|
|
Prepacyte®-CB
|
|
|
— |
|
|
|
22,265 |
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
$ |
199,439 |
|
|
$ |
804,236 |
|
|
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of
August 31, 2016 and November 30, 2015:
|
|
|
|
|
|
|
|
|
| |
|
As of August 31,
2016 |
|
|
As of November 30,
2015 |
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
16,755,419 |
|
|
$ |
16,697,621 |
|
|
Prepacyte®-CB
|
|
|
786,866 |
|
|
|
2,800,325 |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
17,542,285 |
|
|
$ |
19,497,946 |
|
|